Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc J Claeys

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registriesNicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.
Lancet (London, England)|March 23, 2017
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trialE Magnus Ohman, Matthew T Roe, P Gabriel Steg, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomesMaddalena Lettino, Pontus Andell, Uwe Zeymer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registriesUwe Zeymer, Petr Widimsky, Nicolas Danchin, et al.
European Heart Journal. Acute Cardiovascular Care|February 7, 2021
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline groupFrançois Schiele, Suleman Aktaa, Xavier Rossello, et al.
European Heart Journal|May 11, 2026
Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarctionRoberto Lorusso, Matteo Matteucci, Daniele Ronco, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 11, 2026
Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarctionRoberto Lorusso, Matteo Matteucci, Daniele Ronco, et al.
European Heart Journal|January 15, 2014
Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countriesSteen D Kristensen, Kristina G Laut, Jean Fajadet, et al.
The New England Journal of Medicine|September 1, 2015
Cyclosporine before PCI in Patients with Acute Myocardial InfarctionThien-Tri Cung, Olivier Morel, Guillaume Cayla, et al.
European Heart Journal|September 3, 2013
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology, Gilles Montalescot, Udo Sechtem, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registriesNicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.
Lancet (London, England)|March 23, 2017
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trialE Magnus Ohman, Matthew T Roe, P Gabriel Steg, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomesMaddalena Lettino, Pontus Andell, Uwe Zeymer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registriesUwe Zeymer, Petr Widimsky, Nicolas Danchin, et al.
European Heart Journal. Acute Cardiovascular Care|February 7, 2021
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline groupFrançois Schiele, Suleman Aktaa, Xavier Rossello, et al.
European Heart Journal|May 11, 2026
Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarctionRoberto Lorusso, Matteo Matteucci, Daniele Ronco, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 11, 2026
Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarctionRoberto Lorusso, Matteo Matteucci, Daniele Ronco, et al.
European Heart Journal|January 15, 2014
Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countriesSteen D Kristensen, Kristina G Laut, Jean Fajadet, et al.
The New England Journal of Medicine|September 1, 2015
Cyclosporine before PCI in Patients with Acute Myocardial InfarctionThien-Tri Cung, Olivier Morel, Guillaume Cayla, et al.
European Heart Journal|September 3, 2013
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology, Gilles Montalescot, Udo Sechtem, et al.
Pageof 12